
Lusutrombopag was approved for marketing by the U.S. FDA in 2018, manufactured by Lucius Pharmaceuticals, and is indicated for preoperative platelet elevation treatment in patients with chronic liver disease.

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: